NCT00740324View on ClinicalTrials.gov

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

NPO-11

20 mg butylscopolammonium bromide after administration of NPO-11

DRUG

NPO-11

NPO-11 after administration of NPO-11

DRUG

NPO-11

1 mg glucagons after administration of NPO-11

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY